Suchergebnisse - "Sestini, Stefano"

PubPharm (8)

1

Feasibility and Safety of Lung Cancer Screening and Prevention Program During the COVID-19 Pandemic

enthalten in: Chest | 2021

von Milanese, G. | Sabia, F. | Sestini, S. | +8

2

Inflammatory status and lung function predict mortality in lung cancer screening participants

enthalten in: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) | 2018

von Pastorino, U. | Morelli, D. | Marchianò, A. | +7

3

Lung cancer screening with low-dose spiral computed tomography : evidence from a pooled analysis of two Italian randomized trials

enthalten in: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) | 2017

von Infante, M. | Sestini, S. | Galeone, C. | +13

4

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2017

von Verri, C. | Borzi, C. | Holscher, T. | +9

5

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2016

von Pastorino, U. | Boffi, R. | Marchianò, A. | +12

6

Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2016

von Silva, M. | Galeone, C. | Sverzellati, N. | +7

CommentIn: J Thorac Oncol. 2016 Feb;11(2):139-41. - PMID 26811224

7

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

enthalten in: Oncotarget | 2015

von Sestini, S. | Boeri, M. | Marchiano, A. | +8

ErratumIn: Oncotarget. 2019 Oct 15;10(57):6043. - PMID 31666934

8

Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging

enthalten in: Expert review of molecular diagnostics | 2015

von Boeri, M. | Sestini, S. | Fortunato, O. | +4

1
[1]